APA

Emond B., El Khoury A. C., Patel C., Pilon D., Morrison L., Zhdanava M., Lefebvre P., Tandon N. & Joshi K. (20200204). Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. : Current medical research and opinion.

Chicago

Emond Bruno, El Khoury Antoine C, Patel Charmi, Pilon Dominic, Morrison Laura, Zhdanava Maryia, Lefebvre Patrick, Tandon Neeta and Joshi Kruti. 20200204. Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. : Current medical research and opinion.

Harvard

Emond B., El Khoury A. C., Patel C., Pilon D., Morrison L., Zhdanava M., Lefebvre P., Tandon N. and Joshi K. (20200204). Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. : Current medical research and opinion.

MLA

Emond Bruno, El Khoury Antoine C, Patel Charmi, Pilon Dominic, Morrison Laura, Zhdanava Maryia, Lefebvre Patrick, Tandon Neeta and Joshi Kruti. Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. : Current medical research and opinion. 20200204.